Stock Price
2.17
Daily Change
-0.18 -7.66%
Monthly
-3.98%
Yearly
69.53%
Q2 Forecast
2.13

Galectin Therapeutics reported $-2.71M in Interest Income for its fiscal quarter ending in December of 2023.





Interest Income Change Date
AbbVie USD 59M 13M Dec/2025
Galectin Therapeutics USD -2.71M 2.77M Dec/2023
Gilead Sciences USD 95M 7M Dec/2025
Immunic USD -0.24 0.03 Sep/2024
Incyte USD 33.69M 2.93M Mar/2026
Merck USD 69M 27M Dec/2025